crackdown on glp 1 meds The FDA is proposing the removal of three GLP-1 drugs from the 503B bulks list of active ingredients that outsourcing facilities can use to make compounded medicines, the agency announced Thursday SAHPRA and the SAPC Crack

In addition to weight loss, GLP-1s can also change the way your skin looks

A recently published, randomized, placebo-controlled trial found a greater reduction in BMI z-score (0.22 SDs) in adolescents receiving liraglutide compared with placebo

Drugs such as semaglutide may be useful for mental health conditions associated with diabetes, authors say

Novo and Lilly are using their direct-to-consumer online pharmacies to improve adherence, giving them clearer insight into why patients dont fill or refill prescriptions to offer targeted support

- Mean Corpuscular Haemoglobin (MCH)

The FDA has laid out post-marketing safety testing requirements for Lilly's weight-loss pill Foundayo, including clinical trials.